C.M. Bidwell & Associates’s Veracyte VCYT Stock Holding History

C.M. Bidwell & Associates’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.8K	Hold	118	–	–	﹤0.01%	356
2025 Q4	$4.97K	Hold	118	–	–	﹤0.01%	326
2025 Q3	$4.05K	Hold	118	–	–	﹤0.01%	354
2025 Q2	$3.19K	Sell	118 -16	-12%	-$463	﹤0.01%	361
2025 Q1	$3.97K	Buy	134 +4	+3%	+$152	﹤0.01%	335
2024 Q4	$5.15K	Hold	130	–	–	﹤0.01%	330
2024 Q3	$4.42K	Hold	130	–	–	﹤0.01%	348
2024 Q2	$2.82K	Hold	130	–	–	﹤0.01%	393
2024 Q1	$2.88K	Hold	130	–	–	﹤0.01%	395
2023 Q4	$3.58K	Buy	130 +12	+10%	+$290	﹤0.01%	361
2023 Q3	$2.63K	Hold	118	–	–	﹤0.01%	428
2023 Q2	$3K	Hold	118	–	–	﹤0.01%	425
2023 Q1	$2.63K	Hold	118	–	–	﹤0.01%	430
2022 Q4	$2.8K	Buy	118 +78	+195%	+$1.81K	﹤0.01%	407
2022 Q3	$1K	Hold	40	–	–	﹤0.01%	467
2022 Q2	$1K	Hold	40	–	–	﹤0.01%	479
2022 Q1	$1K	Buy	+40	New	+$1.14K	﹤0.01%	517
2020 Q1	–	Sell	-2,860	Closed	-$80K	–	465
2019 Q4	$80K	Hold	2,860	–	–	0.07%	173
2019 Q3	$69K	Sell	2,860 -495	-15%	-$13.2K	0.07%	224
2019 Q2	$96K	Sell	3,355 -690	-17%	-$17.2K	0.1%	179
2019 Q1	$101K	Buy	+4,045	New	+$77.2K	0.1%	175

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

C.M. Bidwell & Associates's VCYT Position: Q1 2026 in Review

C.M. Bidwell & Associates held its Veracyte (VCYT) position steady in Q1 2026 at 118 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #356.

C.M. Bidwell & Associates first reported a position in VCYT in Q1 2019 and has held it in 21 quarters since. The position peaked at $101K in Q1 2019. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

C.M. Bidwell & Associates held 118 shares of Veracyte worth $3.8K as of Q1 2026.
C.M. Bidwell & Associates left its Veracyte share count unchanged in Q1 2026.
Veracyte made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q1 2026, its #356 holding.
C.M. Bidwell & Associates first reported a position in Veracyte in Q1 2019 and has held it in 21 quarters since.
C.M. Bidwell & Associates's Veracyte position peaked at $101K in Q1 2019.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.